Anti-idiotype ovarian cancer vaccine CA-125 can delay relapse and improve measures of QOL

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1300, 2001-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

QOL benefits with palliative chemotherapy in ovarian cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 307, 2001-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

QOL better with carboplatin + paclitaxel for ovarian cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 498, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Depression, anxiety and poor QOL in women with ovarian cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 286, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

A multidisciplinary cardiac rehabilitation programme can improve symptoms, functional performance and QOL among elderly patients with heart failure

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 478, 2005-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Exemestane and tamoxifen both improve QOL

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 649, 2012-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite